ARK Genomic Revolution

Large biotech companies

(ARCG)

£3.38

Previous business day’s close price

‑£0.13 (‑3.82%)

max available period

£3.35

£4.05

19 Apr 24

25 Oct 24

Details

ETF description

The ARK Genomic Revolution is an actively managed ETF that seeks long‑term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.

Issuer details

ARK Invest is an ETF provider specialising in thematic ETFs covering future‑oriented topics, disruptive technologies and megatrends. ARK Invest was founded in the USA in 2014 by economist and now world‑renowned investor Cathie Wood. Since 2016, ARK Invest is also active in the Asia‑Pacific region through a joint venture with the Japanese company Nikko Asset Management. In 2023, the company entered the European market with the acquisition of the European ETF provider Rize ETF.

Index details

This is an actively managed ETF and it does not follow any benchmark.

This ETF is in collections:

Thematics

Actively Managed

Healthcare

Key information

Key investor information

ETF Breakdown

Twist Bioscience Corp

8.7%

CRISPR Therapeutics AG

6.5%

Recursion Pharmaceuticals Inc

6.5%

Caredx Inc

6.1%

Intellia Therapeutics Inc

4.6%

Veracyte Inc

4.5%

Adaptive Biotechnologies Corp

4.4%

Nurix Therapeutics Inc

4.3%

Natera Inc

4.1%

Ionis Pharmaceuticals Inc

4.0%

Beam Therapeutics Inc

4.0%

10x Genomics Inc

3.3%

Arcturus Therapeutics Holdings Inc

3.2%

Schrodinger Inc

3.2%

Personalis Inc

2.6%

Guardant Health Inc

2.5%

Veeva Systems Inc

2.1%

Pacific Biosciences of California Inc

2.0%

Absci Corp

1.9%

AMGEN Inc.

1.9%

Vertex Pharmaceuticals, Inc.

1.9%

Exact Sciences Corp.

1.8%

Accolade Inc

1.6%

Moderna Inc

1.5%

Standard BioTools Inc

1.3%

Regeneron Pharmaceuticals, Inc.

1.3%

Incyte Corp.

1.2%

Butterfly Network Inc

1.1%

Cerus Corp.

1.1%

Compass Pathways Plc

0.9%

908 Devices Inc

0.9%

Prime Medicine Ord Shs

0.8%

Quantum‑Si Incorporated

0.8%

Repare Therapeutics Inc

0.7%

Others

2.8%

£3.38

Previous business day’s close price

Capital at risk

Why InvestEngine

Unbeatable value

From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it

Choice of 700+ ETFs

Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
View our ETF range

Actionable insights

Know exactly which companies, sectors and regions are in your portfolio.

Powerful automation

Grow your wealth the easy way with automated investing features

Easy diversification

Fractional investing lets you put as little as £1 in any ETF.

DIY or Managed

Build and manage your own portfolio or leave it to us.

ETFs have spreads and annual charges and come with risks like market volatility, liquidity, and concentration, and may not always accurately track their index. Past performance and forecasts are not reliable indicators of future results. The value of your investments, including any income, can rise or fall. You may get back less than you originally invested.